Clinical Epidemiology of Cardiac Disease in Renal Transplant Recipients

Seminars in Dialysis

Volumn 16, Issue 2, 2003, Pages 106-110

  Rigatto, Claudio ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; HOMOCYSTEINE; IMMUNOSUPPRESSIVE AGENT; SERUM ALBUMIN;

AGE; ANEMIA; CADAVER DONOR; CARDIOMYOPATHY; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DISEASE MARKER; ECHOCARDIOGRAPHY; GENDER; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; KIDNEY ALLOGRAFT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MORBIDITY; PREVALENCE; RECIPIENT; REVIEW; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE; DIABETIC ANGIOPATHY; GRAFT REJECTION; HEART DISEASE; HEART MUSCLE ISCHEMIA; KIDNEY DISEASE;

DIABETIC ANGIOPATHIES; GRAFT REJECTION; HEART DISEASES; HEART FAILURE, CONGESTIVE; HUMANS; HYPERLIPIDEMIAS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MYOCARDIAL ISCHEMIA; RISK FACTORS;

EID: 0043074897     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-139X.2003.16026.x     Document Type: Review

References (33)

1. Kasiske BL: Risk factors for accelerated atherosclerosis in renal transplant patients. Am J Med 84:985-992, 1988
2. Lindholm A, Albrechtsen D, Frodin L, Tufveson G, Persson NH, Lundgren G: Ischemic heart disease - major cause of death and graft loss after transplantation in Scandinavia. Transplantation 60:451-457, 1995
3. Wilson P, D'Agostino R, Levy D, Belanger A, Silbershatz H, Kannell W: Prediction of coronary heart disease using risk factor categories. Circulation 97:1837-1847, 1998
4. Huting J, Kramer W, Schutterle G, Wizemann V: Analysis of left ventricular changes associated with chronic hemodialysis: a non-invasive follow-up study. Nephron 49:284-290, 1988
5. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE: The outcome and risk factors for left ventricular disorders in chronic uremia. Nephrol Dial Transplant 11:1277-1285, 1996
6. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: The impact of anemia on cardiomyopathy, morbidity and mortality in end stage renal disease. Am J Kidney Dis 28:53-61, 1996
7. Levin A, Thompson CR, Ethier J, Carlisle EJ, Tobe S, Mendelssohn D, Burgess E, Jindal K, Barrett B, Singer J, Djurdjev O: Left ventricular mass index increase in early renal disease. Impact of decline in hemoglobin. Am J Kidney Dis 34:125-134, 1999
8. Rigatto C, Parfrey P, Foley R, Negrijn C, Tribula C, Jeffery J: Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship to ischemic heart disease. J Am Soc Nephrol 13:1084-1090, 2002
9. Rigatto C, Foley R, Jeffery J, Negrijn C, Tribula C, Parfrey P: Electrocardiographic left ventricular hypertrophy in renal transplant recipients: prognostic value and impact of blood pressure and anemia. J Am Soc Nephrolo 14:462-468, 2003
10. Parfrey PS, Harnett JD, Foley RN, Kent GM, Murray DC, Barre PE, Guttmann RD: Impact of renal transplantation on uremic cardiomyopathy. Transplantation 60:908-914, 1995
11. Rigatto C, Foley RN, Kent GM, Guttmann R, Parfrey PS: Long-term changes in left ventricular hypertrophy after renal transplantation. Transplantation 70:570-575, 2000
12. Kasiske BL, Guijarro C, Massy ZA, Wiederkehr MR, Ma JZ: Cardiovascular disease after renal transplantation. J Am Soc Nephrol 7:158-165. 1996
13. Culleton BF, Larson MG, Wilson PWF, Evan JC, Parfrey PS, Levy D: Cardiovascular disease and mortality in a community based cohort with mild renal insufficiency. Kidney Int 56:2214-2219, 1999
14. Senni M, Tribouilloy CM, Rodeheffer RJ, Jacobsen SJ, Evans JM, Bailey KR, Redfield MM: Congestive heart failure in the community: trends in incidence and survival in a 10 year period. Arch Intern Med 159:29-34, 1999
15. Ho K, Pinsky J, Kannel W, Levy D: The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 22:6A-13A, 1993
16. Himelman RB, Landzberg JS, Simonson JS, Amend W, Bouchard A, Merz R, Schiller NB: Cardiac consequences of renal transplantation: changes in left ventricular morphology and function. J Am Coll Cardiol 12:915-923, 1988
17. Larsson O, Attman PO, Beckman-Suurkula M, Wallentin I, Wikstrand J: Left ventricular function before and after kidney transplantation. A prospective study in patients with juvenile-onset diabetes mellitus. Eur Heart J 7:779-791, 1986
18. Deligiannis A, Paschalidou E, Sakellariou G, Vargemezis V, Geleris P, Kontopoulos A, Papadimitriou M: Changes in left ventricular anatomy during haemodialysis, continuous ambulatory peritoneal dialysis and after renal transplantation. Proc Eur Dial Transplant Assoc Eur Ren Assoc 21:185-189, 1985
19. Lai KN, Barnden L, Mathew TH: Effect of renal transplantation on left ventricular function in hemodialysis patients. Clin Nephrol 18:74-78, 1982
20. Ikaheimo M, Linnaluoto M, Huttunen K, Takkunen J: Effects of renal transplantation on left ventricular size and function. Br Heart J 47:155-160, 1982
21. Huting J: Course of left ventricular hypertrophy and function in end-stage renal disease after renal transplantation. Am J Cardiol 70:1481-1484, 1992
22. Torres S, Maximino J, Pereira S, Oliveira A, Henriques C, Sarmento M, Gomes L, Xavier E, Pimenta A: Evolucao morfologica do ventriculo esquerdo apos transplante renal. Estudo ecocardiografico. Rev Port Cardiol 10:497-501, 1991
23. Peteiro J, Alvarez N, Calvino R, Penas M, Ribera F, Castro Beiras A: Changes in left ventricular mass and filling after renal transplantation are related to changes in blood pressure: an echocardiographic and pulsed Doppler study. Cardiology 85:273-283, 1994
24. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: Hypoalbuminemia, cardiac morbidity and mortality in end stage renal disease. J Am Soc Nephrol 7:728-736, 1996
25. Rigatto C, Parfrey P, London G: Cardiac hypertrophy in end-stage renal failure. In: Loscalzo J, London G, eds. Cardiovascular Disease in End-Stage Renal Failure. Oxford: Oxford University Press, 2000:157-175
26. Kasiske B, Harini C, Roel J: Explained and unexplained ischemic heart disease risk after renal transplantation. J Am Soc Nephrol 11:1735-1743, 2000
27. Aker S, Ivens K, Grabensee B, Heering P: Cardiovascular complications after renal transplantation. Transplant Proc 30:2039-2042, 1998
28. Ducloux D, Motte G. Challier B, Gibey R, Chalopin JM: Serum total homocysteine and cardiovascular disease occurrence in chronic stable transplant recipients: a prospective study. J Am Soc Nephrol 11:134-137. 2000
29. Mange K, Cizman B, Joffe M, Feldman H: Arterial hypertension and renal allograft survival. JAMA 283:633-638, 2000
30. Ridker PM, Rifai N, Clearfield M, Downs JR, Weis SE, Miles JS, Gotto AM Jr: Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 344:1959-1965, 2001
31. Eikelboom JW, Lonn E, Genest J Jr, Hankey G, Yusuf S: Homocysteine and cardiovascular disease: a critical review of the epidemiological evidence. Ann Intern Med 131:363-375, 1999
32. Kark JD, Selhub J, Adler B, Gofin J, Abramson JH, Friedman G, Rosenberg IH: Nonfasting plasma homocysteine level and mortality in middle aged and elderly men and women in Jerusalem. Ann Intern Med 131:321-330, 1999
33. Bostom AG, Rosenberg IH, Silbershatz H, Jacques PF, Selhub J, D'Agostino RB, Wilson PW, Wolf PA: Non-fasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham study. Ann Intern Med 131:352-355, 1999